• HOME
  • SIGN UP
  • LOGIN
  • KALC

대한폐암학회

D-15 Today 2025-10-22

  • SIGN UP
  • LOGIN
  • KALC 2025
    • Invitation
    • Overview
    • Committee
    • Venue
    • News & Notice
    • Past KALC
  • PROGRAM
    • Program at a Glance
    • Scientific Program
    • E-poster
    • Invited Faculty
  • SUBMISSION
    • Abstract Submission
    • Presentation Guidelines
    • Awards
  • ATTENDANCE
    • Registration
    • Transportation
    • Accommodation
    • More about Seoul
    • Visa
  • SPONSORSHIP
    • Sponsorship Opportunities
    • Our Sponsors

D-15 Today 2025-10-22

KALC 2025 INTERNATIONAL CONFERENCE NOVEMBER 7THU ~ 8FRI, 2025 LOTTE HOTEL WORLD, SEOUL, KOREA

HOME
  • SIGN UP
    • KALC 2025
    • PROGRAM
    • SUBMISSION
    • ATTENDANCE
    • SPONSORSHIP
    • SIGN UP
  • Login
    • Login
    • Forgotten your ID?
    • Forgotten your password?
    • Sign-Up
  • Login
  • Forgotten your ID?
  • Forgotten your password?
  • Sign-Up

Login

LOGIN

LOGIN

Forgotten your ID Forgotten your Password

Sign up Please sign up if this is your first visit.

Key Dates

  • End

    [Extended]
    Deadline for Abstract Submission

    August 8 (Fri), 2025
  • End

    Notification of Abstract Acceptance

    Mid-August, 2025
  • End

    Deadline for Early-Bird Registration

    September 5 (Fri), 2025
  • End

    [Extended]
    Deadline for Regular Registration

    October 17 (Fri), 2025

Korean Association for Lung Cancer

#1322, Rosedale Officetel, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, 06367, Korea

E-mail. kalc@lungca.or.kr  Tel. +82-2-741-8540

KALC 2025 Secretariat

Abstract & Program

E-mail. scientific.kalcic@innon.co.kr  T. +82-2-6411-7318

Registration

E-mail. kalcic@innon.co.kr  T. +82-2-6411-7307

General

E-mail. kalcic@innon.co.kr  T. +82-2-6411-7378

Copyright © Korean Association for Lung Cancer. All Rights Reserved.

사전등록 양식을 작성하는 모습

25년도 대한폐암학회 연회비를 납부하셔야 회원가로 등록이 가능합니다. 연회비 납부하시겠습니까?

회비 납부하기 비회원으로 등록하기

Oral Presentation 1

  • November 6 (Thu), 14:45-15:35
  • ROOM C (Crystal Ballroom 1)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0125 14:45-14:55 Spatial Characterization of Immunosuppressive Microenvironment in Patients with PD-L1 Discordant Response to Pembrolizumab in Advanced Non-small Cell Lung Cancer Seong-Eun Kim Asan Medical Center Korea
A-0115 14:55-15:05 Delta-like Ligand 3 (DLL3)-based Enrichment Enables Sensitive and Specific Detection of Circulating Tumor Cells During Immunotherapy in Small-cell Lung Cancer Hyung-Joo Oh Chonnam National University Medical School and Hwasun Hospital Korea
A-0088 15:05-15:15 Cereblon (CRBN) Suppresses Lung Adenocarcinoma Cell Migration and Invasion by Facilitating the Degradation of Cystathionine Beta-Synthase (CBS) Hyeon-Seung Yoon Gwangju Institute Of Science And Technology Korea
A-0060 15:15-15:25 Ganoderic Acid-Chitosan Lipid Nanoparticles Attenuate Benzopyrene-Induced Lung Cancer via Alteration of PI3K/Akt/mTOR, NF-kB and MAPK/ERK Signaling Pathway Vikas Kumar Sam Higginbottom University Of Agriculture, Technology & Sciences India
A-0022 15:25-15:35 In Vivo CRISPR Activation Screens Reveal Drivers of Chemoresistance in Small Cell Lung Cancer Jae Heun Chung Pusan National University Yangsan Hospital Korea

Oral Presentation 2

  • November 7 (Fri), 09:10-10:00
  • ROOM C (Crystal Ballroom 1)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0103 09:10-09:20 Impact of Quitting Smoking at Diagnosis on Overall Survival in Lung Cancer Patients: A Comprehensive Meta-Analysis Dongwon Park Hanyang University Medical Center Korea
A-0151 09:20-09:30 Transbronchial Mediastinal Cryobiopsy for Mediastinal Lesions: The First Single-Center Experience in South Korea Min Jee Kim Asan Medical Center Korea
A-0021 09:30-09:40 Combining Deep Learning Radiomics with Clinical Data for Preoperative Prediction of STAS in Stage IA Lung Adenocarcinoma: a Multicenter Study Xiaocui Liu Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology China
A-0222 09:40-09:50 Exosome-based BALF liquid biopsy(ExoBAL)-guided pre-operative lazertinib therapy in potentially resectable EGFR-mutant tumors In Ae Kim Konkuk University Medical Center Korea
A-0099 09:50-10:00 Localized Defense Programs Underlie Prognostic Divergence in GGO and Solid Lung Adenocarcinoma Han Sanghyun Chungbuk National University Hospital Korea

Oral Presentation 3

  • November 7 (Fri), 10:25-11:25
  • ROOM C (Crystal Ballroom 1)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0072 10:25-10:35 Effectiveness and Radiation Pneumonitis of Stereotactic Body Radiation Therapy in High-Risk Patients with Early-Stage Non-Small Cell Lung Cancer Yoo Kyung Choi The Catholic University of Korea Seoul St. Mary's Hospital Korea
A-0048 10:35-10:45 Identification of a novel Golgi Apparatus signature to prognostic stratification and integrative analyses in lung adenocarcinoma Haoran Li Sichuan Cancer Hospital China
A-0077 10:45-10:55 Deep Learning-Driven Reconstruction of Lineage and Immune Plasticity Trajectories in Small Cell Lung Cancer Using Multi-Omics Data Integration Rifaldy Fajar The Integrated Mathematical, Computational, And Data Science For Biomedicine Research Foundation Indonesia
A-0054 10:55-11:05 Tislelizumab vs Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer: Literature Review of Indirect Treatment Comparisons Ji-Youn Han National Cancer Center Korea
A-0025 11:05-11:15 Predictive Value of Inflammatory Biomarkers in EGFR-Mutant NSCLC Treated with Lazertinib: An Interim Analysis of a Prospective Real-World Study (ORIENT) Seung Hyeun Lee Kyung Hee University Medical Center Korea
A-0148 11:15-11:25 Integrated Gene Expression and Network Analysis Identifies Key Pathways in Small Cell Lung Cancer Nadyatul Husna Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang Indonesia

Basic & Translational Research / Biology / Pathology

Basic & Translational Research / Biology / Pathology
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0215 PE1-01 Clinical Relevance of Pleural Tissue Debris Incidentally Obtained During Catheter Drainage for Pleural Effusion Jiwon Kim Kyung Hee University Medical Center Korea
A-0189 PE1-02 A Radiomics-based Nomogram for Preoperative Prediction of Pathological Subtypes in Nodular Lung Adenocarcinoma: a Multicenter Study Xiaocui Liu Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology China
A-0161 PE1-03 Dual Modulation of Redox and Immune Signaling in Lung Cancer via Pharmacoinformatic Study of Benzothiazepine-Based Immunomodulators Targeting Nrf2 and JAK2-JH1 Rizki Rachmad Saputra Universitas Palangka Raya Indonesia
A-0131 PE1-04 Molecular Adaptation Reveals Metabolic and Stress Response Bypass Pathways in Erlotinib-Resistant Non-Small Cell Lung Cancer Subclones Nadyatul Husna Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang Indonesia
A-0118 PE1-05 Uncovering Multi-Layered Resistance Mechanisms to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer Nadyatul Husna Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang Indonesia
A-0093 PE1-06 Natural Triterpenoids of Peronema canescens as Dual Inhibitors of AKT1 and ERK1/2: A Structure-Based Approach for Overcoming Lung Cancer Rizki Rachmad Saputra Universitas Palangka Raya Indonesia
A-0076 PE1-07 Development of a Novel Inhibitor Against nRAS-Mutated Lung Cancers. Vikas Kumar Aiims New Delhi India
A-0059 PE1-08 Solid Lipid Nanoparticle of Ganodric acid ameliorate benzopyrene induced lung cancer in rats Via Alteration of Nrf2/HO-1 Signaling pathway V Kumar Shalom Institute Of Health & Allied Sciences India
A-0236 PE1-09 Decoding the Role of myomiR-206 in Lung Cancer Cachexia and Its Correlation with IL-6 Signaling Divo Helmizar Stan / Perbendaharaan Negara Indonesia
A-0233 PE1-10 Decoding Hematologic Paraneoplastic Syndromes in Lung Cancer: A Critical Approach to Early Diagnosis Aryofri Afan Andalas University Indonesia
A-0220 PE1-11 Establishment of a Lung Organoid Library from Diverse Clinical Samples for Advanced Disease Modeling Joo-Eun Lee Chungnam National University Hospital Korea
A-0208 PE1-12 Role of PFKFB3 in Maintaining Redox Homeostasis and DNA Integrity in Non-Small Cell Lung Cancer Cells Treated with EGFR-TKIs Brijalkumar Patel Gmers Medical College India
A-0207 PE1-13 Follicular lymphoma presenting with solitary pulmonary nodule: two case reports Heae Surng Park Ewha Womans University Medical Center Korea
A-0181 PE1-14 Nutritional and Lifestyle Interventions in Lung Cancer Prevention and Survivorship in Indonesia Helen Try Juniasti Cendrawasih University Indonesia
A-0174 PE1-15 Enhancing Quality of Life in Lung Cancer Patients: Integrating Palliative Care with Immunotherapy and Targeted Therapy Yesika Simbolon Atmajaya University Australia
A-0134 PE1-16 Genetic Analysis of Compositions For Diagnosing Lung Cancer Comprising Peptide Nucleic Acid Probe Complementary To Lung Cancer Related Mutations Ramlah Ramlah Universitas Sulawesi Barat esia Indonesia
A-0100 PE1-17 Spread Through Air Spaces in EGFR-mutated Lung Adenocarcinomas: Prevalence and Prognostic Significance Yeon Bi Han Seoul National University Bundang Hospital Korea
A-0095 PE1-18 Decoding Alternative Splicing-Driven Immune Escape in Rare Lung Adenocarcinoma Subtypes Using Deep Learning and Minor Spliceosome Signatures Rini Winarti Yogyakarta State University Indonesia
A-0081 PE1-19 Integrated Multi-Omics Profiling Identifies CEBPA as an Aging-Related Prognostic Biomarker in NSCLC Jiaqi Zhu Affiliated Hospital Of Nantong University China
A-0038 PE1-20 Investigating the Role and Mechanisms of USP18-Mediated YAP Deubiquitination in Radiation-Induced Lung Injury Haochun Guo Zhongda Hospital, Medical School Of Southeast University China
A-0037 PE1-21 Exploring the protection effects of Taxifolin on alleviating radiation-induced lung injury basing on USP18 Haochun Guo Zhongda Hospital, Medical School Of Southeast University China
A-0035 PE1-22 Comprehensive Analysis of Matrisome-Related Genes Reveals Prognostic Value and Immune Landscape in Lung Cancer Hou Wang Ningbo No.2 Hospital China

Big Data & AI

Big Data & AI
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0096 PE1-23 A Peritumor-based Model Combining 3D Deep Learning and Radiomics for Preoperatively Predicting STAS in Invasive Lung Adenocarcinoma: a Multicenter Study Xiaocui Liu Union Hospital, Tongji Medical College, Huazhong University Of Science And Technology China
A-0244 PE1-24 Machine Learning Algorithms' Use in Plasma Biomarker-Based Lung Cancer Diagnosis Siska Azizah Baiturrahmah Universitya Indonesia
A-0211 PE1-25 An AI-powered holotomography platform for predicting drug response in patient-derived lung cancer organoids Mahn Jae Lee Chungnam National University Hospital Korea
A-0135 PE1-26 Development of Big Data for Predecting Lung Cancar (Study in Asia) Rara Yulianda Sulthan Thaha Saifuddin Islamic State University Indonesia
A-0132 PE1-27 Enhancing using Artificial Intelligence in Detecting Lung Cancer in Asia Rani Marsyanda Sultan Thaha Saifuddin Islamic State University Indonesia
A-0120 PE1-28 A Comprehensive Review of Legal and Ethical in the Implementation of AI & Big Data in Lung Cancer Diagnosis Ferza Alfath Alumnus Universitas Andalas Indonesia
A-0119 PE1-29 AI-Driven Multi-Modal Prediction of Post-Surgical Recurrence in Brain-Metastatic Lung Adenocarcinoma: Integrating Tumor Dormancy, Stromal Remodeling, and TME Immune Exclusion Signals Elfiany Syafruddin Blk Muhammadiyah University Indonesia
A-0075 PE1-30 Comparative Risk of Neurological Adverse Events Between PD-1 and PD-L1 Inhibitors in Korean Lung Cancer Patients: A Nationwide Cohort Study Seung Hyeun Lee Kyung Hee University Medical Center Korea
A-0067 PE1-31 Applying machine learning (ML) and artificial intelligence (AI) techniques to predict the risk of lung cancer in region of Chhattisgarh. Manvendra Singh Hmfa Miet India

Others

Others
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0170 PE1-32 Assessment of the association between expression of Cyclin D1 protein with the clinicopathological characteristics and prognosis of lung cancer Usha J Satanee Nanduba Medical Center India
A-0127 PE1-33 Trends of positive rates of initial screening and repeated screening in national organized population-based lung cancer screening in Korea Nayoung Lee National Cancer Center Korea
A-0217 PE1-34 Economic Burden and Cost-Effectiveness of Lung Cancer Management in Indonesia: Evidence from Smoking-Attributable Mortality and EGFR-Targeted Therapies Pisi Bethania Titalessy Universitas Cenderawasih Indonesia
A-0117 PE1-35 Highly Sensitive Digital Profiling of Tumor-derived Extracellular Vesicle RNA for EML4-ALK Mutations in Non-small Cell Lung Cancer Beomseok Lee Labspinner, Inc. Korea
A-0173 PE1-36 Impact Evaluation of Cigarette Excise and Pricing on Smoking Habits and Lung Cancer Disease in Indonesia Lintong Hottua Simbolon The Pranala Institute Indonesia

Pulmonology / Endoscopy

Pulmonology / Endoscopy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0240 PE1-37 ECMO as a Procedural Bridge for Malignant Airway Obstruction Hyeong Jun Cho The Catholic University of Korea Seoul St. Mary's Hospital Korea
A-0230 PE1-38 Enhancing Early-Stage Lung Cancer Diagnosis: The Role of Bronchoscopic Biomarkers in Improving Accuracy and Personalizing Treatment Roland Helmizar Faculty Of Medicine, Baiturrahmah University Indonesia
A-0121 PE1-39 Initial Experience of EBUS-TBNA in Mongolia: Diagnosing 13R Squamous Cell Carcinoma Without Radial Ultrasound Davaajav Nyamluvsan The First Central Hospital of Mongolia Mongolia

Radiology / Staging / Screening / Epidemiology

Radiology / Staging / Screening / Epidemiology
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0232 PE1-40 Long-Term Projections of Tracheal, Bronchus, and Lung Cancer in Indonesia’s Productive-Age Population Najwa Aisya Putri International Open University Indonesia
A-0225 PE1-41 Contrasting Mortality Patterns of Lung Cancer in Young Adults (25-29 Years) Across Global Socio-Demographic Contexts, 2015-2021 Najwa Aisya Putri International Open University Indonesia
A-0223 PE1-42 Divergent Global Trends in Lung Cancer Mortality Among Young Adults (25-29 Years) by Socio-Demographic Index: Projections to 2050 Najwa Aisya Putri International Open University Indonesia
A-0205 PE1-43 Mapping the Burden of Tracheal, Bronchus, and Lung Cancer: Age-Based and SDI-Level Comparisons from the GBD 2021 Nabila Zahra Athirah Islamic University Of Indonesia Indonesia
A-0204 PE1-44 Unveiling the Burden of Smoking on Lung Cancer in Indonesia: A Quantitative Assessment from 2017 to 2021 Najwa Aisya Putri International Open University Indonesia
A-0031 PE1-45 Indoor air pollution and risk of hypopharyngeal/laryngeal and lung cancers in New Delhi, India Monirujjaman Biswas Jawaharlal Nehru University India
A-0030 PE1-46 Examining the differences between non-smokers and smokers of lung cancer: Insights from a Tertiary Centre in Delhi, India Monirujjaman Biswas Jawaharlal Nehru University India
A-0020 PE1-47 Trends and Survival Outcomes of Lung Cancer Surgery in South Korea, 2015-2019 Chanwoo Kim Chungbuk National University Korea
A-0243 PE1-48 Regional Trends in Lung Cancer in Southeast Asia: Analysis of Mortality Proportion, Daily Life Expectancy (DALYs), and Prevalence Derizal Derizal Ip Trisakti Indonesia
A-0239 PE1-49 Identification of Environmental, Behavioral, and Metabolic Risk Factors for Lung Cancer Mortality: A Statistical Approach Putri Ayu Andalas University Indonesia
A-0201 PE1-50 Preventing Chronic Lung Disease Early: Evidence of the Impact of Parenting and Mental Health from the Indonesian Family Life Survey Derizal Derizal Ip Trisakti Indonesia
A-0087 PE1-51 User Satisfaction and Reading Efficiency of an AI-Based Quality Control System in Korean National Lung Cancer Screening Kang Jegu National Cancer Center Korea
A-0086 PE1-52 Urban-Rural Disparities in Lung Cancer Diagnosis and Treatment in Indonesia: A Nationwide Review Rinita Istiqomah Universitas Jambi Indonesia
A-0074 PE1-53 Single Round LDCT Screening in Men Aged 70 Years: Prevalence of Pulmonary Nodules and Lung Cancer Detection Hyerin Kang Dongtan Sacred Heart Hospital Korea
A-0056 PE1-54 Air Pollution and Lung Cancer in a Changing Climate Through Projected Risks and Molecular Impacts of PM2.5 Exposure Firdian Makrufardi Integrated Medical, Molecular, And Data Science Research Foundation Indonesia
A-0027 PE1-55 Sex-Specific Associations of Total Bilirubin, ALBI, and PALBI with Lung Cancer Risk: Interactions with Smoking and Alcohol Jong Won Shin Asan Medical Center Korea
A-0026 PE1-56 Risk and Incidence of Drug-Induced Interstitial Lung Disease Associated with Anti-Neoplastic Therapy: A Nationwide Population-Based Study in Korea Seung Hyeun Lee College of Medicine, Kyung Hee University, Kyung Hee University Hospital Korea
A-0019 PE1-57 Association between Creatinine and Lung Cancer Risk in Men Smokers: A Comparative Analysis with Antioxidant Biomarkers from the KCPS-II Cohort Jong Won Shin Asan Medical Center Korea

Early / Locally Advanced Non-Small Cell Lung Cancer

Early / Locally Advanced Non-Small Cell Lung Cancer
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0196 PE2-01 FASN's Role in Lung Cancer Stem Cells: A Study of EGFR-Mutant Non-Small Cell Lung Cancer Cells Nilamkumari Naginbhai Patel Esis General Hospital India
A-0171 PE2-02 Financial Management and Clinical Outcomes in Early and Locally Advanced NonSmall Cell Lung Cancer (NSCLC) Fitri Kurnia Universitas Muhammadiyah Sumatera Barat Indonesia
A-0166 PE2-03 The diagnostic accuracy of microRNA 21 as compare to histopathological diagnosis in patients with non small cell lung cancer. Jeegnesh Bholabhai Satanee Nanduba Medical Center India
A-0158 PE2-04 Geriatric Screening Tools in Older Patients Undergoing Concurrent Chemoradiotherapy for Locally Advanced non-Small Cell Lung Cancer Yong-Hyub Kim Chonnam National University Medical School and Hwasun Hospital Korea
A-0124 PE2-05 Hexosamine Biosynthetic Pathway-Mediated Cytoskeletal Reorganization: A Potential Metabolic Mechanism Underlying Early-Stage Non-Small Cell Lung Cancer Lara Beatrice Sunga University Of The Philippines Diliman Philippines
A-0104 PE2-06 Prognostic Value of EGFR Mutation in Resected NSCLC: A Meta-Analysis of Literature Published 2015-2025 Soo Han Kim Pusan National University Hospital Korea
A-0057 PE2-07 Prognostic Significance of Circulating microRNAs in Non-Small Cell Lung Cancer Patients Widia Sari Faculty Of Medicine, Universitas Baiturrahmah Indonesia

Mesothelioma / Thymic & Other Thoracic Malignancies

Mesothelioma / Thymic & Other Thoracic Malignancies
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0203 PE2-08 Uncovering the Growing Burden of Mesothelioma: A Five-Year Analysis in Southeast Asia Using CAGR Nabila Zahra Athirah Islamic University Of Indonesia Indonesia
A-0202 PE2-09 Prognostic Impact of Histologic Subtype, Age, and Systemic Immune-Inflammation Index in Surgically Treated Malignant Pleural Mesothelioma Song Ee Park The Catholic University of Korea Seoul St. Mary's Hospital Korea
A-0200 PE2-10 Exploring Mesothelioma Outcomes Among Working-Age Women: A Five-Year Global Study of Prevalence and Mortality Trends Najwa Aisya Putri International Open University Indonesia
A-0177 PE2-11 Correlation of CT and PET Imaging Responses with Pathological Outcomes after Neoadjuvant Treatment for Thymic Tumors Hyeon Seok Choi Seoul National University Hospital Korea
A-0102 PE2-12 Rare Mutation, Real Impact: Durable Response In EGFR-Mutated Sarcomatoid Lung Cancer Noor Nabila Binti Mohamad National Cancer Institute Malaysia
A-0090 PE2-13 Mathematical Modeling of Treg-TAM Crosstalk and TNFR2 Immunotherapy Timing in Thymic and Mesothelial Tumors Post-Chemotherapy Prihantini Prihantini The Integrated Mathematical, Computational, And Data Science For Biomedicine Research Foundation Indonesia
A-0024 PE2-14 Malignant Pleural Mesothelioma at Pham Ngoc Thach Hospital in 10-Year Retrospective Study Nguyen Son Lam Pham Ngoc Thach Hospital (retired) Vietnam

Radiotherapy

Radiotherapy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0146 PE2-15 Molecular Insights into Melastoma malabathricum’s Anticancer Potential: Advancing Radiotherapy Efficacy in Early-Stage Lung Carcinoma Muhammad Priyadi Universitas Palangka Raya Indonesia
A-0179 PE2-16 Prognostic Impact of Dose to Circulating Blood Cells in Non-Small Cell Lung Cancer Patients after Chemoradiotherapy Byung-Hee Kang Ewha Womans University Medical Center Korea
A-0144 PE2-17 Radiogenomics in Personalised Radiotherapy: Correlation Between Gene Expression and Clinical Outcome Muhammad Irzaq Alumnus Padang State University Indonesia

Surgery

Surgery
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0079 PE2-18 A Comparative Analysis of Sublobar versus Lobar Resection for Early-Stage Non-Small Cell Lung Cancer in Octogenarian Patients Sangil Yun Seoul National University Korea
A-0227 PE2-19 Racial and Ethnic Disparities in Surgical Management of Early-Stage Non-Small Cell Lung Cancer: A population-Based Analysis Ahmed Almezaine Ministry Of Health Egypt
A-0182 PE2-20 Long-Term Outcomes After ICU Discharge Among Lung Cancer Patients: A Longitudinal Analysis of Physical, Cognitive, and Emotional Health Across Age Silmi Rahmani The Pranala Institute Indonesia
A-0176 PE2-21 Caregiver Dynamics and Surgical Recovery in Lung Cancer: Perception, Knowledge, Attitude, and Patient Quality of Life in Indonesia Hepri Ardianson Purba The Pranala Institute Indonesia

Advanced Non-Small Cell Lung Cancer / Chemotherapy / Targeted Therapy / Immunotherapy

Advanced Non-Small Cell Lung Cancer / Chemotherapy / Targeted Therapy / Immunotherapy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0198 PE3-01 Are Bevacizumab Biosimilars Clinically Equivalent in Advanced Non-Squamous NSCLC? Evidence from a Meta-Analysis of 14 RCTs Mohamed Hamouda Elkasaby Faculty Of Medicine, Al-Azhar University Egypt
A-0164 PE3-02 Investigating the Role of Autophagy-Flux Molecules in Overcoming EGFR TKI Resistance in NSCLC Seoree Kim The Catholic University of Korea Bucheon St. Mary's Hospital Korea
A-0123 PE3-03 Designing Targeted Therapies for Lung Cancer using Monobody Scaffolds Targeting sEGFR Tushar Kushwaha All India Institute Of Medical Sciences India
A-0116 PE3-04 Comparison of TKI Monotherapy versus TKI Combined with Radiotherapy or Surgery in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Eun Hye Lee Yonsei University College of Medicine Korea
A-0092 PE3-05 Predictive Value of Baseline Peripheral Lung SUVmax for Immune-Related Pneumonitis in Lung Cancer Patients on Immunotherapy Chaeuk Chung Chungnam National University Hospital Korea
A-0091 PE3-06 Real-World Outcomes of Brigatinib vs Alectinib as Second-Line Therapy After Crizotinib in Advanced ALK-Positive NSCLC Min Jee Kim Asan Medical Center Korea
A-0061 PE3-07 Immune Gene Signatures Predict Response to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer Nadyatul Husna Universitas Andalas/ Dr. Reksodiwiryo Military Hospital Padang Indonesia
A-0023 PE3-08 Efficacy of First-Line Osimertinib in Vietnamese Patients with Stage IV EGFR-Mutant Non-small cell lung cancer Thao Nguyen Hanoi Medical University Hospital Vietnam
A-0224 PE3-09 Comparison of ICI Plus Chemotherapy and Chemotherapy Alone in PD-L1-Negative Advanced NSCLC: A Real-World Analysis Ji Young Park Hallym University Sacred Heart Hospital Korea
A-0213 PE3-10 Osimertinib in EGFRm NSCLC with Brain Metastases: Can Targeted Therapy Rival Surgery or Radiotherapy? Keh Yee Tan Sabah Women & Children Hospital Malaysia
A-0185 PE3-11 Tepotinib Long-Term Efficacy and Safety in Patients with METex14 Skipping NSCLC: Updated Data from ≥3-Years Follow-Up in the VISION Trial Myung-Ju Ahn Samsung Medical Center Sungkyunkwan University School of Medicine Korea
A-0165 PE3-12 Can circulating tumor DNA predict efficacy of pembrolizumab response in patients with metastatic non-small cell lung cancer? Jatinkumar Veljibhai Dhanani Gmers Medical College, Navsari India
A-0157 PE3-13 Quality of Life Outcomes of the ATTLAS Study of Atezolizumab + Bevacizumab and Chemotherapy ( KCSG LU19-04) in EGFR/ALK- NSCLC Eun Joo Kang Korea University Guro Hospital Korea
A-0147 PE3-14 CCT2 Coordinates Proteostasis and beta oxidation to Drive NSCLC Progression and Represents a Therapeutic Vulnerability Sai Fung Yeung The Chinese University Of Hong Kong Hong Kong
A-0145 PE3-15 Response predictors for patients with EGFR-mutant metastatic non-small cell lung cancer receiving tyrosine kinase inhibitor treatment Shweta Jatinkumar Dhanani Gmers Medical College, Navsari India
A-0141 PE3-16 Discovery of Potential KRAS G12C Inhibitors for NSCLC via Structure-Based Virtual Screening of Sotorasib Derivatives Rian Ka Praja Universitas Palangka Raya Indonesia
A-0139 PE3-17 "CYFRA 21-1 as a Standalone Marker and its Role in a Multi-Biomarker Panel for Early Detection of NSCLC" Afreen Mehdi King George's Medical University India
A-0137 PE3-18 Squamous Cell Lung Carcinoma with ROS1CD74 fusion 75% Rearrangement and PD-L1 50% CPS Overexpression: A Case Report Edith Mari Timbol Philippine General Hospital Philippines
A-0106 PE3-19 The Application Potential of Exosomes in Immunotherapy for Lung Cancer Pengpeng Lu Medical School Of Nantong University China
A-0098 PE3-20 A Twist in the Tumour Tale: The Unexpected Target in EGFR-Mutated Lung Squamous Cell Carcinoma Izzati Rosli National Cancer Institute Putrajaya Malaysia Malaysia

Palliative Care

Palliative Care
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0247 PE3-21 Effectiveness of Music Therapy, Aromatherapy, and Quranic Recitation on Psychological and Physical Symptoms in Post-Chemotherapy Lung Cancer Patients in Indonesia Yusril Yusril Uin Sjech M. Djamil Djambek Bukittinggi Indonesia
A-0242 PE3-22 Multidisciplinary Palliative Care in Lung Cancer: Enhancing Pain Management, Symptom Burden, and Psychological Well-being Mutia Setia Ningsih Andalas University Indonesia
A-0214 PE3-23 Innovation Non-Pharmaceutical in Oncology: The Impact of Virtual Reality in Lung Cancer Care Derizal Derizal Ip Trisakti Indonesia
A-0184 PE3-24 Malnutrition in Geriatric Lung Cancer Disease in Asia: An Investigation of Critical Risks of Nutritional Status Abdul Igna Gopur Lukmana The Pranala Institute Indonesia
A-0183 PE3-25 High-VAF Tier-3 Variants and Post-Progression Survival in Oncogene-Addicted Stage IV NSCLC: A Retrospective Study So-yun Kim Chungnam National University Hospital Korea
A-0140 PE3-26 Indonesian Community-Based Palliative Care Model Development: Applying Gotong Royong Philosophy and Community Support Mega Dwi Septivani Padang State Polytechnic Indonesia
A-0089 PE3-27 Deep Learning Model for Predicting Immune Toxicity and Survival in End-Stage Lung Cancer from Peripheral Blood Single-Cell Data Sahnaz Vivinda Putri International University Semen Indonesia Indonesia

Small Cell Lung Cancer / Neuroendocrine Tumors

Small Cell Lung Cancer / Neuroendocrine Tumors
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0212 PE3-28 Genetic Analysis of EGFR and CYP3A4 Variants and Their Impact on Tyrosine Kinase Inhibitor Metabolism in Lung Cancer Putrya Hawa Indonesia Defense University Indonesia
A-0168 PE3-29 Real-World Efficacy and Safety of First Line Chemo Immunotherapy in Extensive-Stage Small Cell Lung Cancer: Alignment With Pivotal Trials Miran Han Samsung Medical Center Korea
A-0018 PE3-30 Self-oxygenating PROTAC Microneedles for Spatiotemporally-Tunable Protein Degradation and Enhanced Small cell lung cancer Therapy Meng Hou Shanghai Pulmonary Hospital China
A-0226 PE3-31 Epidemiology and Survival Outcomes of Pulmonary Large Cell Neuroendocrine Carcinoma: A Population-Based Study Ahmed Almezaine Ministry Of Health Egypt